Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Upadacitinib improved multiple immune-related conditions in one patient.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

The excimer laser is a promising and safe treatment for frontal fibrosing alopecia.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

A patient's grey hair regained color during treatment with adalimumab.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Clofazimine effectively treated ashy dermatosis in a patient.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.